Argumentos a favor da prescrição de Quimioterapia Citostática (Qt) no Carcinoma Pulmonar de não Pequenas Células (CPNPC)*

Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small cell lung cancer and stable disease after two or three cycles of MACC: Results of a randomized prospective study.

Cancer, 63 (1989), pp. 428-432

Medline

[6.]

R. Cellerino, D. Tummarello, A. Piga.

Chemotherapy or not in advanced non-small cell lung cancer.

Lung Cancer, 6 (1990), pp. 99-109

[7.]

T. Lechevaller, et al.

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients.

J Clin Oncol, 12 (1994), pp. 360-367

http://dx.doi.org/10.1200/jco.1994.12.2.360 | Medline

[8.]

M.H. Cullen.

The MIC regimen in non-small cell lung cancer.

Lung Cancer, 9 (1993), pp. 81-89

[9.]

M.H. Cullen.

Trials of radical radiotherapy versus chemotherapy plus radical radiotherapy in non-small cell lung cancer.

Sem Oncol, 21 (1994), pp. 34-41

[10.]

R.O. Dillman, et al.

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.

N Engl J Med, 323 (1990), pp. 940-945

http://dx.doi.org/10.1056/NEJM199010043231403 | Medline

[11.]

K.R. Durrant, R.J. Berry, F. Ellis.

Comparison of treatment policies in inoperable bronchial carcinoma.

Lancet, 10 (1971), pp. 715-719

[12.]

W.K. Evans.

Rationale for the treatment of non-small cell lung cancer.

Lung Cancer, 9 (1993), pp. S5-S14

[13.]

R. Feld.

Chemotherapy versus best supportive care for unresectable non small cell lung cancer: is it really worthwhile?.

Lung Cancer, 8 (1993), pp. 391-396

[14.]

P.A. Ganz, C.M. Haskell, R.A. Figlin, N.L. Soto, J. Siaus.

Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the functional living index-cancer.

Cancer, 61 (1988), pp. 849-856

Medline

[15.]

R.J. Gralla.

Preoperative and treatment adjuvant chemo therapy in non-small cell lung cancer.

Semin Oncol, 15 (1988), pp. 8-12

Medline

[16.]

A. Gregor, et al.

Radical radiotherapy and chemotherapy in localized inoperable non-small-cell lung cancer. A randomized trial.

J Natl Cancer Lost, 85 (1993), pp. 997-999

[17.]

R. Grilli, A.D. Oxman, J.A. Julian.

Chemotherapy for advanced non-small-cell lung cancer: How much benefit is enough?.

J Clin Oncol, 11 (1993), pp. 1866-1872

http://dx.doi.org/10.1200/jco.1993.11.10.1866 | Medline

[18.]

F.I.H. Hansen.

Advanced non-small-cell lung cancer: to treat or not to treat?.

J Clin Oncol, 5 (1987), pp. 1711-1712

http://dx.doi.org/10.1200/jco.1987.5.11.1711 | Medline

[19.]

J.R. Hardy, T. Noble, I.E. Smith.

Symptom relief with moderate dose chemotherapy(Mitomycin-C, Vinblastine and Cisplatin) in advanced non small cell lung cancer.

Br J Cancer, 60 (1989), pp. 764-766

Medline

[20.]

C.M. Haskell.

Chemotherapy and survival of patients with non-small cell lung cancer.

A contrary view Chest, 99 (1991), pp. 1325-1326

Medline

[21.]

M.B. Hazuka, P.A. Bunn.

Controversies in the non-surgical treatment of stage III non-small cell lung cancer.

Am Rev Respir Dis, 145 (1992), pp. 967-977

http://dx.doi.org/10.1164/ajrccm/145.4_Pt_1.967 | Medline

[22.]

E.C. Holmes, M. Gail.

Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma.

J Clin Oncol, 4 (1986), pp. 710-715

http://dx.doi.org/10.1200/jco.1986.4.5.710 | Medline

[23.]

L. Jaakkinmainen, P.J. Goodwin, J. Pater, P. Warde, N. Murray, E. Rapp.

Counting the costs of chemotherapy in a National Cancer Institute of cancer randomised trial of non-small cell lung cancer.

J Clin Oncol, 8 (1990), pp. 1301-1309

http://dx.doi.org/10.1200/jco.1990.8.8.1301 | Medline

[24.]

B.E. Jonson.

Biologic and molecular prognostic factors. Impact on treatment of patients with non-small cell lung cancer.

Chest, 107 (1995), pp. 287S-290S

Medline

[25.]

D.A. Karnowsky, W.H. Abelmann, L.F. Craver, J.F. Burchenal.

The use of nitrogen mustards in the palliative treatment of carcinomas.

Cancer, 1 (1948), pp. 634

[26.]

T. Lad, L. Rubinstein, A. Sadeghi.

The benefit of adjuvant treatment for ressected locally advanced non-small cell lung cancer.

J Clin Oncol, 6 (1988), pp. 9-17

http://dx.doi.org/10.1200/jco.1988.6.1.9 | Medline

[27.]

W.T. Leung, et al.

Combined chemotherapy and radiotherapy versus best supportive care in the treatment of inoperable non-small cell lung cancer.

Oncology, 49 (1992), pp. 321-326

Medline

[28.]

R.C. Lilenbaum, M.R. Green.

Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer.

J Clin Oncol, 1 (1993), pp. 1391-1402

[29.]

P. Marino, S. Pampallona, A. Preatoni, A. Cantoni, F. Invernizzi.

Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature.

Chest, 106 (1994), pp. 861-865

Medline

[30.]

G.A. Masters, E.E. Vokes.

Should non-small cell carcinoma of the lung be treated with chemotherapy? Pro: Chemo therapy is for non-small cell lung cancer.

Am J Respir Crit Care Med, 151 (1995), pp. 1285-1287

http://dx.doi.org/10.1164/ajrccm.151.5.7735574 | Medline

[31.]

C.M. Moinpour.

Measuring quality of life: an emerging science.

Semin Oncol, 21 (1994), pp. 48-63

Medline

[32.]

Non-Small Cell Lung Cancer Colloborative Group.

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials.

BMJ, 311 (1995), pp. 899-909

Medline

[33.]

B. Raby, J. Pater, W.J. Mackillop.

Does knowledge guide practice? Another look at the management of non-small cell lung cancer.

J Clin Oncol, 13 (1995), pp. 1904-1911

http://dx.doi.org/10.1200/jco.1995.13.8.1904 | Medline

[34.]

Rappe, et al.

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer. Report of a Canadian multicenter randomized trial.

J Clin Oncol, 6 (1988), pp. 633-641

http://dx.doi.org/10.1200/jco.1988.6.4.633 | Medline

[35.]

R. Rosell.

A randomized trial of Mitomycin/Ifosfamide/Cisplatin preoperative chemotherapy plus surgery alone in stage IIIA non-small cell lung cancer.

Semin Oncol, 21 (1994), pp. 28-33

Medline

[36.]

R. Rosel, et al.

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

N Engl J Med, 330 (1994), pp. 153-158

http://dx.doi.org/10.1056/NEJM199401203300301 | Medline

[37.]

J.A. Roth, et al.

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone resectable stage IIIA non-small cell Lung cancer.

J Natl Cancer Inst, 86 (1994), pp. 673-680

Medline

[38.]

Schaake-Konig, et al.

Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer.

N Engl J Med, 326 (1992), pp. 524-530

http://dx.doi.org/10.1056/NEJM199202203260805 | Medline

[39.]

M.L. Slevin, et al.

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.

BMJ, 300 (1990), pp. 1458-1460

Medline

[40.]

I.E. Smith.

Palliative chemotherapy for advanced non-small cell lung cancer. Time to reappraise its role.

BMJ, 308 (1994), pp. 429-430

Medline

[41.]

R. Sotto-Mayor.

Quimioterapia no carcinoma pulmonar de não pequenas células (CPNPC) em fase avançda.

Arq SPPR, 9 (1992), pp. 13-20

[42.]

R. Sotto-Mayor.

Tratamento do cancro do pulmão não pequenas células (CPNPC) - Estadio III. Quimioterapia citostática.

Arq SPPR, IX (1992), pp. 303-308

[43.]

P.J. Souquet, et al.

Polychemotherapy in advanced non-smal cell lung cancer. A meta-analysis.

Lancet, 342 (1993), pp. 19-21

Medline

[44.]

N. Thatcher, M. Ranson, H. Anderson.

Chemotherapy in non-small cell lung cancer.

Eur Respir Mon, 1 (1995), pp. 269-305

[45.]

S. Thongprasert, P. Sanguanmitra, T. Umsawas-Di.

Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy.

Proc ASCO, 14 (1995), pp. 358

[46.]

J. Trédaniel, E. Lepage, M. Marty, A. Hirsch.

La chimiothérapie apporte un bénèfice aux cancers bronchiques non à petites cellules inoperables.

Rev Mal Resp, 7 (1990), pp. 493-496

[47.]

E.E. Vokes, J.D. Bitran.

Non-small cell lung cancer. Toward the next plateau.

Chest, 106 (1994), pp. 659-661

Medline

[48.]

E.E. Vokes, J.D. Bitran, N.J. Vogelzang.